Described herein is a PCR-based assay termed SSPE-qPCR. The purpose of this method is to quantify DPC repair on plasmid DNA transfected into repair deficient and proficient mammalian cells. This assay is rapid, quantitative, extremely flexible, and directly measures repair activity. While this report focuses on the use of this methodology to study repair of DPCs, results presented below illustrate that repair of any lesion that blocks Taq polymerase can be studied using this methodology.
The rationale behind the development of this method is to gain insight into the mechanisms through which mammalian cells repair DPCs. Unlike other types of DNA damage, DPCs are massively diverse1,2. Studies have demonstrated that hundreds of cellular proteins can become crosslinked to DNA and that for each protein there are, in principle, numerous amino acid side chains that could become covalently attached to cellular DNA3. In addition, there are numerous chemical attachment points for proteins onto the DNA backbone, including several positions on the nucleotide bases as well as on the ribose sugar4,5. This chemical diversity raises the prospect that distinct biochemical pathways may be relied upon to repair different types of DPCs. It was with this concern in mind that the SSPE-qPCR assay was developed.
Several techniques have been developed to gain insight into the molecular biology of cellular DPC repair. The following provides an overview of the major approaches that have been developed, with a summary of the major strengths and weaknesses each possess. It is worth stressing that while this summary focuses on studies of DPC repair in mammalian cell culture systems, significant contributions to the current model of DPC repair have been made using microbial and cell-free systems that are not discussed in this manuscript.
Perhaps the easiest strategy that can be taken to gain insight into the genetics of DPC repair is to assess the respective sensitivity to cell death observed in wild-type and mutant cells exposed to agents that induce DPCs6,7. This strategy is relatively fast, inexpensive, and does not require specialized expertise beyond the ability to perform basic cell culture techniques. Counterbalancing these advantages are numerous limitations to this approach including the following. First, the assay does not directly measure DNA repair. The working assumption underlying this strategy is that inactivating mutations in genes encoding relevant DNA repair proteins results in an accumulation of DNA damage that triggers programmed cell death. However, mutations in genes encoding non-DNA-repair proteins could, in principal, enhance (or reduce) cellular sensitivity to xenobiotic-induced cell death. Second, agents that create DPCs invariably induce other types of DNA damage (one exception is 5-aza-2'-deoxycytadine, but this agent also depletes cellular methyltransferase levels8). Consequently, it is conceivable that enhanced cellular hypersensitivity to the agent in question may reflect defects in repair of interstrand crosslinks or other lesions. Third, as was mentioned above, DPCs represent a vastly heterogeneous class comprised of different types of chemical crosslinks, involving different protein partners. It is possible that while repair of one or more sub-types of these lesions may be altered in a particular genetic background, this difference may not be sufficient to significantly alter cellular hypersensitivity to death induced by this agent. In summary, while this strategy represents an attractive starting point, the limitations outlined above highlight the importance of pursuing other, more direct methods to study the kinetics of DPC repair.
A number of related approaches have been developed to achieve this objective. For instance, investigators have developed methods to distinguish between 'free' DNA and 'protein-bound' DNA9,10,11. Using these approaches, it is possible to compare steady-state levels of DPCs or following exposure to a DPC-producing agent in different genetic backgrounds. The two strategies that have been most widely used involve separating DPC-containing DNA from free DNA using either a nitrocellulose membrane binding strategy or KCl/SDS precipitation12,13. In the former approach cells are lysed and passed through a nitrocellulose filter. Because nitrocellulose binds protein, the filter retains protein-linked DNA, permitting free DNA to pass through. In the latter strategy protein-bound DNA is separated from free DNA based on the fact that SDS binds to protein but not DNA, and can be precipitated by the addition of KCl. Consequently, protein-linked DNA becomes insoluble while unbound DNA remains in solution. DPC-containing DNA can then be quantitated using radiolabeled thymidine (if cells were initially metabolically labeled) or by a DNA-selective fluorescent dye like Hoechst 33258. These methods are reproducible and require a small number of steps. However, they do not provide information regarding the nature of the chemical crosslink through which protein is attached to DNA. Furthermore, it is important to note, these assays may over-estimate DPC repair by falsely scoring incomplete repair, i.e., proteolytic processing to smaller DNA-peptide crosslinks that may not be as easily trapped or precipitated, as bona fide DNA repair.
Comet assays can be used to visualize DPC formation in cells14. In these experiments, the presence of DPCs decrease DNA migration which can then be reversed by pretreating with proteinase K. Therefore, the length of the tail can be used to estimate DPC formation. However, as mentioned above, DPC-forming drugs create other types of DNA damage which could alter tail length. This protocol is also highly technical and requires expertise and training in confocal imaging.
Mass spectrometry can be used to study DPC repair kinetics following treatment with crosslinking agents15,16,17. These experiments treat cells with DPC-forming agents and isolate DPCs via biotin capture or phenol:chloroform (1:1) extraction. Mass spectrometry can then be used to identify the crosslinked proteins or quantitate the amount of DPCs formed over time. The major advantage of this approach is the nature of the data produced. It is possible to precisely catalog the types of proteins that become crosslinked following exposure to a xenobiotic, however, this protocol is expensive, time consuming, and is limited by the type of crosslink that can be detected.
Maizels et al. developed a sensitive 'RADAR' (rapid approach to DNA adduct recovery) assay to quantitate immunodetection of DNA-protein adducts as well as an ELISA-based RADAR assay18,19. These assays are especially useful for trapping DNA-protein intermediates that transiently form in cells and generate samples suitable for mass spectroscopy to identify new protein adducts. This immunodetection assay relies on the availability of antibodies to capture the DNA-protein crosslink and, therefore, may not be capable of detecting degraded DNA-peptide adducts that form during repair. Recently, a specific DPC repair pathway linked to DNA replication and a DNA-dependent metalloprotease Spartan was discovered in which DPCs are proteolyzed to smaller peptides during repair20,21. Inherited mutations in this gene are associated with Ruijs-Aalfs syndrome in humans, a disease characterized by genomic instability, premature ageing, and liver cancer22. Mice with genetically engineered Spartan gene defects display similar phenotypes23.
Host-cell reactivation of transcriptional activity has been used to study the repair of defined lesions present on transfected plasmid DNA substrates24,25. In these experiments, plasmid containing DPCs (or other types of DNA lesions) that block the transcription of a reporter, such as luciferase, are transfected into cells. Luminescence measurements taken 24 - 72 h later are then correlated with DPC repair. However, these indirect repair assays are incapable of detecting repair events earlier than 24 h post-transfection and cannot distinguish between RNA polymerase bypass of partially repaired substrates and complete repair.
Each of the methods described above has advantages and has contributed to the current model of DPC repair. However, the SSPE-qPCR assay circumvents several of the limitations associated with these other approaches and consequently can provide more specific insight into DPC repair mechanisms. For example, the SSPE-qPCR assay can directly measure repair of site-specific DPCs on DNA in intact mammalian cells. This method is versatile and has been used to obtain repair results following transfection in hamster and human cell lines. Transfection of the plasmid can be performed using lipofection or electroporation in cultured mammalian cell lines. It also ensures that only repair of defined DPCs is measured, and not other types of DNA damage induced by most DPC-forming agents. The SSPE-qPCR is easy to perform, inexpensive, and rapid. Results obtained using this assay have detected repair events as early as 2 h post-transfection. Using this method, variables that may influence DPC repair outcomes can be studied in a manner that is sensitive and efficient. For example, the role of transcription in DPC repair has yet to be rigorously evaluated. Due to the flexibility of the SSPE-qPCR assay, the crosslinking site of the DPC can be manipulated to address this question. In addition, introduction of an origin of replication into the DPC-bearing plasmid can be used to address the influence of replication on DPC repair. Additionally, multiple crosslinks can be created on the plasmid to examine differences in repair of a single DPC versus multiple crosslinks. These are questions that would be difficult to answer using chromosomal DNA but can easily be addressed using the SSPE-qPCR assay. Overall, the SSPE-qPCR assay requires purified, plasmid DNA in microgram quantities containing a lesion of a known location. Adducts besides DPC can be used in this assay, however, the lesion must be capable of blocking extension by Taq polymerase.